down arrow

Huakang Biomedical Holdings Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG4644W1069
  • HKG: 8622
HKD
0.19
-0.23 (-54.7%)

Sep 23

HKG

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Vincent Medical Holdings Ltd.
Uni-Bio Science Group Ltd.
Suzhou Basecare Medical Corp. Ltd.
Elegance Optical International Holdings Ltd.
Broncus Holding Corp.
Biosino Bio-Technology & Science, Inc.
Kaisa Health Group Holdings Ltd.
Sun Hing Vision Group Holdings Ltd.
Kelfred Holdings Ltd.
Huakang Biomedical Holdings Co. Ltd.
King International Investment Ltd.

Why is Huakang Biomedical Holdings Co. Ltd. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Huakang Biomedical Holdings Co. Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Huakang Biomedical Holdings Co. Ltd.
-100.0%
1.26
81.98%
Hang Seng Hong Kong
-5.07%
-0.26
18.70%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
4.33%
EBIT Growth (5y)
1.25%
EBIT to Interest (avg)
-6.39
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.65
Sales to Capital Employed (avg)
0.47
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.82
EV to EBIT
-7.18
EV to EBITDA
-13.53
EV to Capital Employed
4.11
EV to Sales
2.01
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-57.34%
ROE (Latest)
-15.14%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET PROFIT(HY)

Higher at HKD -2.68 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 3.52 times

DEBTORS TURNOVER RATIO(HY)

Highest at 2.66 times

NET SALES(Q)

Highest at HKD 18.87 MM

OPERATING PROFIT(Q)

Highest at HKD -0.12 MM

OPERATING PROFIT MARGIN(Q)

Highest at -0.63 %

-6What is not working for the Company
INTEREST(HY)

At HKD 0.28 MM has Grown at 280.81%

OPERATING CASH FLOW(Y)

Lowest at HKD -7.84 MM

Here's what is working for Huakang Biomedical Holdings Co. Ltd.

Net Profit
Higher at HKD -2.68 MM
than preceding 12 month period ended Jun 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Net Sales
Highest at HKD 18.87 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Net Sales
At HKD 18.87 MM has Grown at 42.52%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Operating Profit
Highest at HKD -0.12 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (HKD MM)

Operating Profit Margin
Highest at -0.63 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Inventory Turnover Ratio
Highest at 3.52 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 2.66 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Huakang Biomedical Holdings Co. Ltd.

Interest
At HKD 0.28 MM has Grown at 280.81%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Operating Cash Flow
Lowest at HKD -7.84 MM
in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Footer loading